BioAroundWorld Event April 19 & April 20
April 19 & 20, 2022
On April 19th & 20th, 2022, BioAroundWorld as the first global platform for cross-border knowledge sharing in the biopharma sector successfully launched its first online event. This event brought 2 round table discussions, 3 case studies, and 1 expert sharing and invited many biopharma company executives, investors, and experts to share their valuable insights and successful industry experience.
ROULDTRABLE DISCUSSION TOPIC l: “KEY CONSIDERATIONS AND STRATEGIES ACCELERATING RARE DISEASE DRUG DEVELOPMENT?”
MODERATOR: Joan Shen, Chief Executive Officer and Founder, NeuShen Therapeutics
PANELISTS:
• Shawn Xiang, CEO, RareStone Group
• Dewan Zeng, Vice President, Head of Search and Evaluation, Business Development, BeiGene
• Benjamin Yerxa, CEO, Opus Genetic
ROUNDTABLE DISCUSSION TOPIC ll: “GLOBAL CAPITAL MARKET FORECAST”
MODERATOR: Wendy Pan, Partner, Goodwin
PANELISTS:
• Echo Hindle-Yang, Founder & CEO, MSQ Ventures
• Shoaib Ghias, Partner, Goodwin
• Bosco Yiu, Partner, Goodwin
• Philipe Gallon, Managing Director, Moelis & Company
CASE STUDY #1: OVERLAND & ADCT
HOST: Echo Hindle-Yang, Founder & CEO, MSQ Ventures
SPEAKERS:
• Ed Zhang, Co-founder and CEO, Overland Pharmaceutical
• Peter Greaney, Head Of Corporate Development, ADC Therapeutics
CASE STUDY #2: How to Maximize Your Asset’s Value for Deal Making: A Case Study Presentation by NeoImmuneTech
SPEAKERS:
• Samuel Zhang, PhD, MBA, Chief Business Officer, NeoImmuneTech, Inc.
CASE STUDY #3: THE CURRENT LANDSCAPE AND FUTURE PERSPECTIVES OF GALECTIN-3 INHIBITORS IN FIBROSIS-RELATED DISEASES AND CANCER
SPEAKERS:
• Stephanie Oestreich, Chief Business Officer, Galecto